CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
We report that cryoablation of primary tumors synergizes with anti-CTLA-4 treatment to mediate rejection of secondary tumors in the TRAMP mouse model of prostate cancer. T cells...